SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041163
Filing Date
2021-08-05
Accepted
2021-08-05 07:00:53
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krtx-10q_20210630.htm   iXBRL 10-Q 2105005
2 EX-31.1 krtx-ex311_9.htm EX-31.1 9823
3 EX-31.2 krtx-ex312_6.htm EX-31.2 9804
4 EX-32.1 krtx-ex321_7.htm EX-32.1 8505
  Complete submission text file 0001564590-21-041163.txt   6960441

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA krtx-20210630.xsd EX-101.SCH 49053
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krtx-20210630_cal.xml EX-101.CAL 60285
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krtx-20210630_def.xml EX-101.DEF 120415
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20210630_lab.xml EX-101.LAB 371554
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20210630_pre.xml EX-101.PRE 263303
10 EXTRACTED XBRL INSTANCE DOCUMENT krtx-10q_20210630_htm.xml XML 1247237
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 211146221
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences